Last updated: 2026-09-06 18:08:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
The Oncology Institute, Inc. (TOI) operates in the SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE sector and is listed on NASDAQ. The stock is currently priced at --, with a market capitalisation of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from -- to --. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- | |
-- |
The Oncology Institute, Inc. (TOI) last closed at $-- as of --, -- from the previous close of $--.
During the latest regular trading session, TOI traded between $-- and $--, with a volume of -- shares. The closing price was -- and --.
Over the past seven days, The Oncology Institute, Inc. (TOI) moved from $5.12 to $5.13, representing a gain of 0.20% ($0.01).
The stock traded between $4.70 and $5.32 during the period. The latest price is near the upper end of the 7-day range, indicating range-bound.
The average daily volume was 1.36 million shares, down versus the previous seven-day period, indicating lower trading activity.
Starling Oncology Inc provides oncology care services in community settings. Its services include cancer diagnosis and treatment, clinical trials, transfusion services, and other oncology care delivery models for patients.
| Industry | SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE |
| Employees | 641 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of The Oncology Institute, Inc. (TOI) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.